BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression - Zeng, Furong; Li, Yayun; Meng, Yu; Sun, Huiyan; He, Yi; Yin, Mingzhu; Chen, Xiang; Deng, Guangtong (Experimental & molecular medicine, 2023)
Keywords: 13/109; 13/2; 13/31; 13/51; 13/95; 14/1; 38/47; 38/91; 631/67/1813/1634; 64; 64/60; 692/308/575; 82; 82/80; Antitumor activity; Antitumor agents; Apoptosis; Biomedical and Life Sciences; Biomedicine; Cancer; Cancer therapies; Cell cycle; Cell Cycle Proteins; Cell death; Cell Line, Tumor; Cell Proliferation; FDA approval; Growth Differentiation Factor 15 - genetics; Growth Differentiation Factor 15 - pharmacology; Humans; Inhibitor drugs; Kinases; Medical Biochemistry; Melanoma; Melanoma - drug therapy; Molecular Medicine; Nuclear Proteins - metabolism; Proteins; Stat3 protein; Stem Cells; Sunitinib - pharmacology; Synergism; Targeted cancer therapy; Transcription Factors - metabolism; Xenograft Model Antitumor Assays; Xenografts; 생화학